PD-1 inhibitors combined with paclitaxel and cisplatin in first-line treatment of esophageal squamous cell carcinoma (ESCC): a network meta-analysis

Abstract Background The combinations of PD-1 inhibitors with paclitaxel/cisplatinum (PD-1 + TP) and fluoropyrimidine/cisplatinum (PD-1 + FP) both have been shown to improve overall survival (OS) and progression-free survival (PFS) in patients with previously untreated, advanced esophageal squamous c...

Full description

Bibliographic Details

Published in:	BMC Cancer
Main Authors:	Jia Zhao, Simeng Zhang, Xiaoyu Guo, Ce li, Bowen Yang, Xiujuan Qu, Shuo Wang
Format:	Article
Language:	English
Published:	BMC 2023-12-01
Subjects:	Esophageal squamous carcinoma Paclitaxel Cisplatin PD-1 inhibitor Meta analysis
Online Access:	https://doi.org/10.1186/s12885-023-11715-3